| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| delta-9-tetrahydrocannabinol less than 2.5 mg/mL + cannabidiol 25 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol less than or equal to 1 mg/mL + cannabidiol 25 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol less than 2 mg/mL + cannabidiol 25 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| cannabidiol 33.33 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 10 mg/mL + cannabidiol 15 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| cannabidiol 240 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| cannabidiol 200 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| elasomeran 100 microgram/mL injection, 2.5 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 8.3 mg/mL + cannabidiol 1.7 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 5 mg/mL + cannabidiol 5 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| cannabidiol 15 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| cannabidiol 20 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| cannabidiol 30 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol less than 0.3% + cannabidiol 40 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| cannabidiol 50 mg/mL oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 14% + cannabidiol less than 0.1% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 22% + cannabidiol less than 0.1% bud |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol less than 1% + cannabidiol 14% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol less than 0.2% + cannabidiol 50 mg/2 g cream, application |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 7% + cannabidiol 9% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 30% + cannabidiol less than 1% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dupilumab 200 mg/1.14 mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dupilumab 100 mg/0.67 mL injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dupilumab 300 mg/2 mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 2.25 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| faricimab 6 mg/0.05 mL intraocular injection, 0.24 mL vial |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| anifrolumab 300 mg/2 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tebentafusp 100 microgram/0.5 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| asciminib 20 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| bilastine 20 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| lenalidomide 7.5 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| lenalidomide 20 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| lenalidomide 2.5 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| thalidomide 150 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| thalidomide 200 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| darunavir 75 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 15 mg/mL + cannabidiol 24 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 24% + cannabidiol less than 0.1% bud |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 30% + cannabidiol less than 0.1% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 28% + cannabidiol less than 0.1% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 22% + cannabidiol less than 1% bud |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| faricimab 6 mg/0.05 mL intraocular injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 22% + cannabidiol less than 0.1% bud |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
| methionine 500 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 15% + cannabidiol less than 0.1% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| desloratadine 2.5 mg/5 mL oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol less than 1% + cannabidiol 14% bud, 5 g |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| glycomacropeptide and essential amino acids with vitamins and minerals powder for oral liquid, 40 g sachet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tafenoquine 50 mg dispersible tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| selumetinib 25 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| ponesimod 20 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| selumetinib 10 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tirzepatide 10 mg/0.5 mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tirzepatide 12.5 mg/0.5 mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tirzepatide 2.5 mg/0.5 mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tirzepatide 7.5 mg/0.5 mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tirzepatide 15 mg/0.5 mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tirzepatide 5 mg/0.5 mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tozinameran 15 microgram/0.3 mL + famtozinameran 15 microgram/0.3 mL injection, 2.25 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| treosulfan 1 g injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| treosulfan 5 g injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| inert substance diluent, 13.5 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| amsacrine 75 mg/1.5 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| estetrol 14.2 mg + drospirenone 3 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| influenza quadrivalent geriatric vaccine 2023 injection, 0.7 mL syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| influenza quadrivalent adjuvanted geriatric vaccine 2023 injection, 0.5 mL syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| elasomeran 25 microgram/0.5 mL + davesomeran 25 microgram/0.5 mL injection, 2.5 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| influenza quadrivalent vaccine 2023 injection, 0.5 mL syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| influenza quadrivalent cell based vaccine 2023 injection, 0.5 mL syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tozinameran injection, 0.4 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol less than 1% + cannabidiol 16% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 6% + cannabidiol 6% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 22% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 21% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| elexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 24% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| elasomeran 25 microgram/0.5 mL + davesomeran 25 microgram/0.5 mL injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| esmolol hydrochloride 100 mg/10 mL injection, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| meningococcal A 10 microgram/0.5 mL + meningococcal C 10 microgram/0.5 mL + meningococcal W135 10 microgram/0.5 mL + meningococcal Y 10 microgram/0.5 mL conjugate vaccine injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| maribavir 200 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| vosoritide 560 microgram injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| glycomacropeptide formula with docosahexaenoic acid and low phenylalanine oral liquid, 237 mL bottle |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| vosoritide 400 microgram injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| upadacitinib 45 mg modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| vosoritide 1.2 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| delta-9-tetrahydrocannabinol 50 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| cannabidiol 115 mg/mL + cannabigerol less than 5 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| cannabidiol 25 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| povidone-iodine 5 cm x 5 cm medicated dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| dostarlimab 500 mg/10 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| tazemetostat 200 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| avacopan 10 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| patisiran 10 mg/5 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| relugolix 40 mg + estradiol 1 mg + norethisterone acetate 500 microgram tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| mobocertinib 40 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| ivosidenib 250 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| pralsetinib 100 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| deucravacitinib 6 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| edaravone 30 mg/20 mL injection, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
| belzutifan 40 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|